Pillar Healthcare Launches Groundbreaking Research to Demonstrate Nutritional Support Can Help Infertile Men Conceive
New study investigates the impact of pre-Conceive on key male fertility markers, building on a decade of innovation in reproductive health.
Douglas, Isle of Man; 20th of October 2025.
Over the past few decades, male reproductive health has seen a concerning decline, with infertility emerging as a growing global challenge. As awareness increases, so too does the need for safe, effective, and evidence-based solutions to support male fertility.
Pillar Healthcare, a leader in reproductive health innovation, is announcing the launch of a new clinical research project focused on male infertility and the efficacy of its nutritional supplement, pre-Conceive.
This landmark study aims to evaluate the supplement's impact on key male fertility parameters including sperm count, motility, morphology, and overall seminal health. This study is designed to expand upon their original, pioneering research that first demonstrated the clinical potential of pre-Conceive in supporting male reproductive health.
Male factor infertility contributes to approximately 50% of infertility cases worldwide, yet it remains critically under-researched and underserved. Pillar Healthcare is taking decisive action to address this gap through this clinical study, continuing to demonstrate the efficacy of pre-Conceive in relation to male factor infertility.
“With this research, we intend to firmly reestablish pre-Conceive as an evidence-backed solution for men facing fertility challenges; putting scientifically grounded support back in their hands. We believe and have demonstrated that nutrition plays a fundamental role in reproductive health,” said Mark Whitney of Pillar Healthcare, “and this research aims to provide more clinical evidence that pre-Conceive can make a measurable difference for men who are trying to conceive.”
pre-Conceive is a comprehensive, scientifically formulated nutritional blend specifically developed to support reproductive health. In pre-Conceive’s previous independent study, the results demonstrated significant improvements across multiple parameters associated with male fertility, in just ninety days! Founded in 2012, with the goal of addressing rising infertility rates, pre-Conceive was launched into the European market. Over the past decade, pre-Conceive has supported thousands of people to conceive and have healthy children.
This new clinical study will build on that foundation with a dedicated focus on male-specific outcomes, aiming to deliver robust clinical data that underscores the efficacy of pre-Conceive as a frontline, non-invasive fertility support option for men.
Men interested in participating in the study, particularly those with a prior diagnosis of infertility, are encouraged to view our application page here or contact Pillar Healthcare directly at study@preconceive.co.uk to learn more.
